Could a drug-discovery robot be named on a patent as an “inventor”? Usually to obtain a patent, the invention must not be obvious to a person of skill in the relevant field. But it seems conceivable that an algorithm could identify drug candidates that are entirely non-obvious to human experts… Amy Nick tackles AI inventorship in addition to other legal, regulatory and commercial issues pertaining to AI in pharma. Elsewhere, you’ll find articles on the rise of single use, economic incentives in clinical trials, as well as kickstarting Alzheimer’s R&D.
All the best, James Strachan, Deputy Editor
|